MEGAN LILLI: Open Payments
NPI 1427595651 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$107 in 5 payments from 2 companies in 2025. Trend: 2023 $24 · 2024 $39 · 2025 $107
Food & beverage: $107
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: NUCALA, DUPIXENT.
Industry payments across MD — which companies pay providers there.
